Company intelligence / Profile preview
Cilcare
Montpellier, Occitanie, Francecilcare.com ↗
- Ownership
- Private
- Employees
- ~45
- Development stage
- Phase 2
01
Overview
Cilcare has developed a robust pipeline focused on treating cochlear synaptopathy using its lead candidate CIL001, which is set to enter Phase IIa trials in both Europe and the US in 2025. The company leverages advanced AI-driven digital biomarkers to improve patient selection and therapy evaluation. It has also established strategic partnerships with major pharma companies such as Shionogi Ltd., who hold an exclusive option to license global rights to key assets. Preclinical studies are ongoing for additional candidates like CIL003. The company recently completed a €40M Series A round to accelerate its clinical programs.
- Therapeutic areas
- OtherRare DiseasesNeurology
- Modalities
- Small molecules (lead asset CIL001 is a small molecule)Potentially gene and cell therapies (as a CRO/R&D partner for others)
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Shionogi Ltd.: Exclusive option agreement for global rights to lead assets including CIL001/CIL003.France’s Bpifrance via France2030 funds.FACCNE (French American Chamber of Commerce New England): business development/networking support.
Beyond the preview
Go deeper on Cilcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cilcare.